Loading patent…
OwnerYun Cheng, Ruihe Yu +1inventors
InventorsYUN CHENG, RUIHE YU, WANZHOU ZHAO
Estimating the term…
The present invention provides the use of hepatitis C virus immunogenic peptides or derivative thereof in the manufacture of a pharmaceutical for preventing or treating arthritis, wherein the peptide or derivative thereof is a peptide represented by formula I or pharmaceutically acceptable salt or ester thereof. The present invention further provides a method for treating arthritis, including administering a pharmaceutical containing therapeutically effective amount of said peptide or derivative thereof to a patient. Xaa1-Gln-Xaa2-Xaa3-Thr-Ser-Gly-Xaa4 (formula I), wherein, Xaa1 is deleted, or Xaa1 is Ala, Gly, Val, Leu or Ile, Xaa2 is Thr or Ser, Xaa3 is Tyr, Phe or Trp, and Xaa4 is deleted, or Xaa4 is Ala, Gly, Val, Leu, Ile or Pro.
Use of a peptide represented by formula I or derivative thereof in the manufacture of a pharmaceutical for preventing or treating arthritis, the derivative comprising a pharmaceutically acceptable salt or ester of the peptide:
A method for treating arthritis, comprising administering a pharmaceutical containing therapeutically effective amount of the peptide of formula I or derivative thereof to a patient, where the derivative comprises a pharmaceutically acceptable salt or ester of the peptide:
Dependencies are inferred from the claim text.